CacheBy
ELK Biotechnology Cleaved-Factor Xa activated HC (I235) rabbit pAb
원본

ELK Biotechnology Cleaved-Factor Xa activated HC (I235) rabbit pAb

상품 한눈에 보기

Cleaved-Factor Xa activated HC (I235) rabbit pAb는 인간 FA10 유래 펩타이드로 제작된 폴리클로날 항체로, WB와 ELISA에 적합합니다. 비타민 K 의존성 응고인자 X를 인식하며, 30kD 밴드를 검출합니다. -20°C에서 1년 보관 가능합니다.

판매단위
pk
카탈로그 보기

카탈로그

2개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
ELK Biotechnology ES5189-100UL Cleaved-Factor Xa activated HC (I235) rabbit pAb, 100UL pk판매 단위 pk ·
재고 확인 필요
402,000원VAT 포함 442,200원
ELK Biotechnology ES5189-50UL Cleaved-Factor Xa activated HC (I235) rabbit pAb, 50UL pk판매 단위 pk ·
재고 확인 필요
301,000원VAT 포함 331,100원

ELK Biotechnology · ELK Biotechnology Cleaved-Factor Xa activated HC (I235) rabbit pAb

Cleaved-Factor Xa activated HC (I235) rabbit pAb

제품 정보

항목 내용
Product name Cleaved-Factor Xa activated HC (I235) rabbit pAb
Alternative Names F10; Coagulation factor X; Stuart factor; Stuart-Prower factor
Applications WB; ELISA
Recommended Dilutions Western Blot: 1/500 - 1/2000
ELISA: 1/20000
Not yet tested in other applications.
Immunogen The antiserum was produced against synthesized peptide derived from human FA10. AA range: 216-265
Storage -20°C / 1 year
Host Rabbit
Clonality Polyclonal
Isotype IgG
Concentration 1 mg/ml
Observed Band 30 kD
GeneID (Human) 2159
Human Swiss-Prot No P00742
Cellular Localization Secreted
Species Reactivity Human; Mouse; Rat

Background

This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by one or more disulfide bonds; the light chain contains two EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases.
The mature factor is activated by the cleavage of the activation peptide by factor IXa (intrinsic pathway) or by factor VIIa (extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca²⁺, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity.

ELK Biotechnology 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.